Introducing New Blogger Ameet Sarpatwari
Ameet Sarpatwari, J.D., Ph.D., is a research fellow at Harvard Medical School and member of the Program On Regulation, Therapeutics, And Law (PORTAL) [Twitter: @PORTAL_Research] in the Division of...
View ArticleNew BoH Feature: Monthly Round-Up of What to Read on Pharma Law and Policy
Each month, the Program On Regulation, Therapeutics, And Law (PORTAL) in the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women’s Hospital/Harvard Medical School reviews the...
View ArticleMonthly Round-Up of What to Read on Pharma Law and Policy
By Ameet Sarpatwari and Aaron S. Kesselheim Each month, the Program On Regulation, Therapeutics, And Law (PORTAL) in the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women’s...
View ArticleMonthly Round-Up of What to Read on Pharma Law and Policy
By Ameet Sarpatwari and Aaron S. Kesselheim Each month, the Program On Regulation, Therapeutics, And Law (PORTAL) in the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women’s...
View ArticleCall for Postdoctoral Fellowship Applications: The Harvard Medical...
By Ameet Sarpatwari and Aaron S. Kesselheim The Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women’s Hospital Department of Medicine and Harvard Medical School invites its 2015...
View ArticleMonthly Round-Up of What to Read on Pharma Law and Policy
By Ameet Sarpatwari and Aaron S. Kesselheim Each month, members of the Program On Regulation, Therapeutics, And Law (PORTAL) review the peer-reviewed medical literature to identify interesting...
View ArticleMonthly Round-Up of What to Read on Pharma Law and Policy
By Ameet Sarpatwari and Aaron S. Kesselheim Each month, members of the Program On Regulation, Therapeutics, And Law (PORTAL) review the peer-reviewed medical literature to identify interesting...
View ArticleEnsuring Timely Approval Of Generic Drugs
By Ameet Sarpatwari and Aaron S. Kesselheim Cross posted from Health Affairs Blog Having saved US consumers over $1.5 trillion in the past decade, generic drugs are one of the most cost-effective...
View ArticleMonthly Round-Up of What to Read on Pharma Law and Policy
By Ameet Sarpatwari and Aaron S. Kesselheim Each month, members of the Program On Regulation, Therapeutics, And Law (PORTAL) review the peer-reviewed medical literature to identify interesting...
View ArticleMonthly Round-Up of What to Read on Pharma Law and Policy
By Ameet Sarpatwari and Aaron S. Kesselheim Each month, members of the Program On Regulation, Therapeutics, And Law (PORTAL) review the peer-reviewed medical literature to identify interesting...
View ArticleMonthly Round-Up of What to Read on Pharma Law and Policy
By Ameet Sarpatwari and Aaron S. Kesselheim Each month, members of the Program On Regulation, Therapeutics, And Law (PORTAL) review the peer-reviewed medical literature to identify interesting...
View ArticleLunch Talk & Book Launch Tomorrow, 10/28: FDA in the 21st Century
Book Launch: FDA in the 21st Century October 28, 2015 12:00 PM Wasserstein Hall, Milstein East C Harvard Law School, 1585 Massachusetts Ave., Cambridge, MA [Map] In September 2015, Columbia University...
View ArticleMonthly Round-Up of What to Read on Pharma Law and Policy
By Ameet Sarpatwari and Aaron S. Kesselheim Each month, members of the Program On Regulation, Therapeutics, And Law (PORTAL) review the peer-reviewed medical literature to identify interesting...
View ArticleMonthly Round-Up of What to Read on Pharma Law and Policy
By Ameet Sarpatwari and Aaron S. Kesselheim Each month, members of the Program On Regulation, Therapeutics, And Law (PORTAL) review the peer-reviewed medical literature to identify interesting...
View ArticleMonthly Round-Up of What to Read on Pharma Law and Policy
By Ameet Sarpatwari and Aaron S. Kesselheim Each month, members of the Program On Regulation, Therapeutics, And Law (PORTAL) review the peer-reviewed medical literature to identify interesting...
View ArticleMonthly Round-Up of What to Read on Pharma Law and Policy
By Ameet Sarpatwari and Aaron S. Kesselheim Each month, members of the Program On Regulation, Therapeutics, And Law (PORTAL) review the peer-reviewed medical literature to identify interesting...
View ArticleExpanding Coercive Treatment Is The Wrong Solution For The Opioid Crisis
By Leo Beletsky, Wendy Parmet, and Ameet Sarpatwari Cross posted from Health Affairs Blog Amidst a surging crisis of opioid abuse and overdoses, many policymakers have called for expanded use of...
View ArticleMonthly Round-Up of What to Read on Pharma Law and Policy
By Ameet Sarpatwari and Aaron S. Kesselheim Each month, members of the Program On Regulation, Therapeutics, And Law (PORTAL) review the peer-reviewed medical literature to identify interesting...
View ArticleMonthly Round-Up of What to Read on Pharma Law and Policy
By Ameet Sarpatwari and Aaron S. Kesselheim Each month, members of the Program On Regulation, Therapeutics, And Law (PORTAL) review the peer-reviewed medical literature to identify interesting...
View ArticleMonthly Round-Up of What to Read on Pharma Law and Policy
By Ameet Sarpatwari and Aaron S. Kesselheim Each month, members of the Program On Regulation, Therapeutics, And Law (PORTAL) review the peer-reviewed medical literature to identify interesting...
View Article